Effects of pharmacological treatment on metabolomic alterations in animal models of depression
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Numerous studies have investigated metabolite alterations resulting from pharmacological treatment in depression models although few quantitative studies explored metabolites exhibiting constant alterations. This study aimed to identify consistently dysregulated metabolites across such studies using a knowledgebase-driven approach. This study was based on 157 studies that identified an assembly of 2757 differential metabolites in the brain, blood, urine, liver, and feces samples of depression models with pharmacological medication. The use of a vote-counting approach to identify consistently upregulated and downregulated metabolites showed that serotonin, dopamine, norepinephrine, gamma-aminobutyric acid, anandamide, tryptophan, hypoxanthine, and 3-methoxytyramine were upregulated in the brain, while quinolinic acid, glutamic acid, 5-hydroxyindoleacetic acid, myo-inositol, lactic acid, and the kynurenine/tryptophan ratio were downregulated. Circulating levels of trimethylamine N-oxide, isoleucine, leucine, tryptophan, creatine, serotonin, valine, betaine, and low-density lipoprotein were elevated. In contrast, levels of alpha-d-glucose, lactic acid, N-acetyl glycoprotein, glutamine, beta-d-glucose, corticosterone, alanine, phenylacetylglycine, glycine, high-density lipoprotein, arachidonic acid, myo-inositol, allantoin, and taurine were decreased. Moreover, 12 metabolites in urine and nine metabolites in the liver were dysregulated after treatment. Pharmacological treatment also increased fecal levels of butyric acid, acetic acid, propionic acid, and isovaleric acid. Collectively, metabolite disturbances induced by depression were reversed by pharmacological treatment. Pharmacological medication reversed the reduction of brain neurotransmitters caused by depression, modulated disturbance of the tryptophan-kynurenine pathway and inflammatory activation, and alleviated abnormalities of amino acid metabolism, energy metabolism, lipid metabolism, and gut microbiota-derived metabolites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737
Gut microbial metabolites as multi-kingdom intermediates
Krautkramer, K. A., Fan, J., & Bäckhed, F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0438-4 · Cited by 1,398
Global Burden of Disease and the Impact of Mental and Addictive Disorders
Rehm, J., & Shield, K. D. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0997-0 · Cited by 1,388
van de Wouw, M., Boehme, M., Lyte, J. M., Wiley, N., Strain, C., O'Sullivan, O., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2018) · The Journal of Physiology · doi:10.1113/jp276431 · Cited by 789 · cited 1×
“Clinical evidence also demonstrated that fecal levels of SCFAs were negatively correlated with depression scale scores [53].”
BackgroundA Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
Nemet, I., Saha, P. P., Gupta, N., Zhu, W., Romano, K. A., Skye, S. M., Cajka, T., Mohan, M. L., Li, L., Wu, Y., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.016 · Cited by 784
How do antidepressants work? New perspectives for refining future treatment approaches
Harmer, C. J., Duman, R. S., & Cowen, P. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30015-9 · Cited by 616
Quinolinic acid, the inescapable neurotoxin
Guillemin, G. J. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08485.x · Cited by 595 · cited 1×
“Existing evidence suggests that immune activation promotes the transformation of tryptophan to kynurenine in the circulation, ultimately leading to the accumulation of quinolinic acid in the brain [46, 47].”
BackgroundWang, Z., Bergeron, N., Levison, B. S., Li, X. S., Chiu, S., Jia, X., Koeth, R. A., Li, L., Wu, Y., Tang, W. H. W., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy799 · Cited by 496
Gong, S., Miao, Y.-L., Jiao, G.-Z., Sun, M.-J., Li, H., Lin, J., Luo, M.-J., & Tan, J.-H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117503 · Cited by 460 · cited 1×
“In rodents, cortisol and corticosterone are endogenous glucocorticoids induced by stressful conditions through activation of the hypothalamic-pituitary-adrenal (HPA) axis [41], disturbance of which have been implicated in the pathophysiology of depression [42].”
Background
Cited by
Teixeira, A. L., Martins, L. B., Berk, M., & Bauer, M. E. (2022) · Clinical Science · doi:10.1042/cs20211106 · Cited by 22
Manf/ewsr1/anxa6 pathway might as the bridge between hypolipidemia and major depressive disorder
Xu, K., Zheng, P., Zhao, S., Wang, M., Tu, D., Wei, Q., Feng, J., Wang, H., Chen, J., & Xie, P. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02287-0 · Cited by 22
Self-citationGawlik-Kotelnicka, O., Sobczak, M., Palma, J., Popławska, M., Skonieczna-Żydecka, K., Plewka, M., Pawliczak, R., & Strzelecki, D. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.05.035 · Cited by 4
“…was found to decrease the levels of C4i and increase C4n in a rat model of depression [56]., while different classes of anti-depressants appeared to increase the faecal levels of C2, C3, C4n, and C5i after treatment in animal models of depression [57]; however, no subgroup analyses were conducted.”
Metadata
- Authors
- Pu, J., Liu, Y., Gui, S., Tian, L., Yu, Y., Wang, D., Zhong, X., Chen, W., Chen, X., Chen, Y., Chen, X., Gong, X., Liu, L., Li, W., Wang, H., & Xie, P.
- Venue
- Translational Psychiatry
- Published
- 2022-04-29
- Volume
- 12
- Issue
- 1
- Pages
- 175-175
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W4225121626
- Cited by
- 45
- References
- 20
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of pharmacological treatment on metabolomic alterations in animal models of depression. https://app.cochat.ai/papers/10.1038/s41398-022-01947-5
- The paper
- Pu, J., Liu, Y., Gui, S., Tian, L., Yu, Y., Wang, D., Zhong, X., Chen, W., Chen, X., Chen, Y., Chen, X., Gong, X., Liu, L., Li, W., Wang, H., & Xie, P. (2022). Effects of pharmacological treatment on metabolomic alterations in animal models of depression. Translational Psychiatry. https://doi.org/10.1038/s41398-022-01947-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.